Author | David Coeffic, MD


European Experience With Irinotecan Plus Fluorouracil/Folinic Acid or Mitomycin

August 01, 1998

ByDavid Khayat, MD, PhD|Marian Gil-delgado, MD, PhD|Eric-charles Antoine, MD|David Coeffic, MD|A. Benhammouda, MD|J. P. Grapin, MD|Gerard Bastian, PhD

Tremendous progress has been made in the medical treatment of advanced colorectal cancer during the past 2 to 3 years, due to the availability of several new drugs. Of these new agents, irinotecan (CPT-11 [Camptosar]) seems